Hammadi, R., Bakir, M., Zamil, G. (2025). The Correlation of Anti-mullerian hormone (AMH) level with anthropometric measurements in premenopausal women. , 24(1), 147-155. doi: 10.52573/ipmj.2025.152243
Rana Faisal Hammadi; Mohanned Mohammed Bakir; Gumar Oudah Zamil. "The Correlation of Anti-mullerian hormone (AMH) level with anthropometric measurements in premenopausal women". , 24, 1, 2025, 147-155. doi: 10.52573/ipmj.2025.152243
Hammadi, R., Bakir, M., Zamil, G. (2025). 'The Correlation of Anti-mullerian hormone (AMH) level with anthropometric measurements in premenopausal women', , 24(1), pp. 147-155. doi: 10.52573/ipmj.2025.152243
Hammadi, R., Bakir, M., Zamil, G. The Correlation of Anti-mullerian hormone (AMH) level with anthropometric measurements in premenopausal women. , 2025; 24(1): 147-155. doi: 10.52573/ipmj.2025.152243

The Correlation of Anti-mullerian hormone (AMH) level with anthropometric measurements in premenopausal women

Iraqi Postgraduate Medical Journal
Article 20, Volume 24, Issue 1, January 2025, Pages 147-155    PDF (680.5 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2025.152243
Authors
Rana Faisal Hammadi* 1; Mohanned Mohammed Bakir2; Gumar Oudah Zamil3
1Ministry of health/ public health department/central public health laboratory
2Minisrty of health / public health department/ central public health laboratory
3Ministry of health / public health department / central public health laboratory
Abstract
Background :
Anti-Müllerian hormone (AMH) can serve as a good biomarker for the ovarian reserve that can predict female fertility, studying the biological factors that impact AMH levels is necessary for predicting reproductive health outcomes . Obesity (general obesity by body mass index and central obesity by waist circumference), is associated with negative reproductive outcomes that could be related to its impact on AMH level . Female fecundity begins to decrease after women reach the age of 30 years for multifactorial causes that could be hormonal changes .
Objective :
The study aims to find the association of Anti-mullerian hormone (AMH) level , as a biomarker for ovarian reserve , with general and central obesity , and other anthropometric measurements in premenopausal women.
Subjects and Methods :
This is a descriptive cross sectional study enrolled a total of 270 Iraqi women in the reproductive age . Height ,Weight and Waist Circumference were measured for all participants .Serum AMH has been analyzed using Enzyme Linked immunofluorescence Assay technique (ELFIA). Subjects were divided into three groups according to their body mass index BMI, and into two groups depending on WHO criteria for central obesity, and into three groups according to their susceptibility to metabolic risk, and into four groups according to their age. Statistical analyses were performed using SPSS software.
Results :
AMH level was significantly lower in obese and overweight women than in normal weight women. women with increased and substantially increased risk for metabolic complication have significantly lower AMH level than those with no metabolic risk.
Same for women with central obesity than those without it and married women than in singles.
Conclusion :
AMH has a negative association with Body mass index , Waist Circumference , and age .
Keywords
Anti-Müllerian hormone (AMH); Body mass index; Central obesity
References
  1. Rzeszowska M, Leszcz A, Putowski L, Hałabiś M, Tkaczuk-Włach J, Kotarski J, Polak G. "Anti-Müllerian hormone: structure, properties and appliance". Ginekologia Polska. 2016;87:669–74. doi:5603/gp.2016.0064. PMID27723076.
  2. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP. "Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells". Cell.  1986;45:685–98. doi:1016/0092-8674(86)90783-X. PMID3754790. S2CID 32395217.
  3. Imbeaud S, Faure E, Lamarre I, Mattéi MG, di Clemente N, Tizard R, Carré-Eusèbe D, Belville C, Tragethon L, Tonkin C, Nelson J, McAuliffe M, Bidart JM, Lababidi A, Josso N, Cate RL, Picard JY. "Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor". Nature Genetics.  1995;11:382–88. doi:1038/ng1295-382. PMID7493017. S2CID 28532430.
  4. van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, Broekmans FJ. "Relationship of serum antimüllerian hormone concentration to age at menopause". The Journal of Clinical Endocrinology and Metabolism. 2008;93: 2129–34. doi:1210/jc.2007-2093. PMID18334591.
  5. Nilsson E, Rogers N, Skinner MK. "Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition".2007;134:209–21.
  6. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH (2011). "A validated model of serum anti-müllerian hormone from conception to menopause". PLOS ONE. 6 (7): e22024. Bibcode:..622024K. doi:10.1371/journal.pone.0022024. PMC3137624. PMID 21789206.
  7. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. "The physiology and clinical utility of anti-Mullerian hormone in women". Human Reproduction Update. 2014;20:370–85. doi:1093/humupd/dmt062. PMID24430863 .
  8. Fryar CD, Gu Q, Ogden CL, Flegal KM. "Anthropometric Reference Data for Children and Adults: United States, 2011-2014". Vital Health Stat 3 Anal Stud. 2016;39:1-46.
  9. WHO Consultation on Obesity (‏1999: Geneva, Switzerland)‏& World Health Organization (2000) . "Obesity : preventing and managing the global epidemic". World Health Organization. https://iris.who.int/handle/10665/42330
  10. Pasquali R, Patton L, Gambineri A.. " Obesity and infertility". Opin. Endocrinol. Diabetes Obes. 2007;14:482–87. doi: 10.1097/MED.0b013e3282f1d6cb.
  11. Marshall NE, Spong CY. "Obesity, pregnancy complications, and birth outcomes". Semin Reprod Med. 2012;30:465–71. doi: 10.1055/s-0032-1328874.
  12. Rich-Edwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al.. "Physical activity, body mass index, and ovulatory disorder infertility". Epidemiology 2002;13:184–90.
  13. Gesink Law DC, Maclehose RF, Longnecker MP.. " Obesity and time to pregnancy". Hum Reprod. 2007;22:414–20. doi: 10.1093/humrep/del400.
  14. van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Burggraaff JM, et al.. "Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women". Hum Reprod 2008;23:324–28. doi: 10.1093/humrep/dem371.
  15. Robker RL, Akison LK, Bennett BD, Thrupp PN, Chura LR, Russell DL, et al.(2009) . "Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women". Clin. Endocrinol. Metab 2009;941:1533-40 .
  16. Juliano Augusto Brum Scheffer, Bruno Scheffer, Rafaela Scheffer, Fabio Florencio, Michael Grynberg, and Daniel Mendez Lozano . " Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF? ". JBRA Assist Reprod. 2018;22:215–20. doi: 5935/1518-0557.20180043
  17. Katherine L. Rosewell, Thomas E. CurryJr.. "Encyclopedia of Reproduction" (Second Edition), 2018;2:250-54 .
  18. Oldfield AL, Kazemi M & Lujan ME. "Impact of obesity on anti-Mullerian hormone (AMH) levels in women of reproductive age". Journal of Clinical Medicine 2021;10: (https://doi.org/10.3390/jcm10143192).
  19. Jaswa EG, Rios JS, Cedars MI, Santoro NF, Pavone MEG, Legro RS & Huddleston HG. "Increased body mass index is associated with a nondilutional reduction in antiMullerian hormone". Journal of Clinical Endocrinology and Metabolism 2020;105:3234–42. (https://doi. org/10.1210/clinem/dgaa436).
  20. Albu D & Albu A.. "The relationship between anti-Mullerian hormone serum level and body mass index in a large cohort of infertile patients". Endocrine 2019;63:157–63. (https://doi.org/10.1007/s12020-018-1756-4).
  21. Sahmay S, Usta T, Erel CT, Imamoğlu M, Küçük M, Atakul N & Seyisoğlu H. "Is there any correlation between amh and obesity in premenopausal women? " , Archives of Gynecology and Obstetrics 2012; 286 :661–65. (https://doi.org/10.1007/s00404-012-2363-x).
  22. Halawaty S, ElKattan E, Azab H, ElGhamry N & Al-Inany H.. "Effect of obesity on parameters of ovarian reserve in premenopausal women". Journal of Obstetrics and Gynaecology Canada 2010;32: 687–90. (https:// doi.org/10.1016/s1701-2163(16)34573-x).
  23. Dólleman M, Verschuren WM, Eijkemans MJ, Dollé ME, Jansen EH, Broekmans FJ & van der Schouw YT. "Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study". Journal of Clinical Endocrinology and Metabolism 2013; 98 :2106–15. (https://doi.org/10.1210/jc.2012-3995).
  24. Zahra Heidar, Sarah Bahramzadeh, Mahtab Motevasselian, Behnazamir Nazari. "The Relationship Between Body Mass Index and Serum Anti-Mullerian Hormone Levels, " Acta Medica Mediterranea, 2018;34:329–35, (https://doi.org/ 10.19193/0393-6384_2018_2_52).
  25. Reyam E. Ahmed, Makarim Q. Al-lami. ."Anti-Mullerian Hormone and Follicle Stimulating Hormone as Markers of Ovarian Aging in a Sample of Iraqi Women ". Iraqi Journal of Science, ( 2016;57:1671–79.
  26. Skałba, P., Cygal, A., Madej, P., Dąbkowska-Huć, A., Sikora, J., Martirosian, G.,Romanik, M. and Olszanecka-Glinianowicz, M.. " Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic and hormonal disturbances in women with and without polycystic ovary syndrome? " . J. Obstet. Gynecol. Reprod. Biol., 2011;158:254-59.
  27. Buyuk, E., Seifer, D.B., Illions, E.V., Grazi, R. and Lieman, H. "Elevated body mass index is associated with lower serum anti-Müllerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve". Fertil. Steril.2011;95:2364-68.
  28. Sarah Lim, Sue Kim, Oksoo Kim, Bohye Kim, Heeja Jung, Kwang-PilK, Hyangkyu Lee. "Correlations among anti-Müllerian hormone levels, body mass index and lipid profile in reproductive-aged women. " Nursing Open, 2021;8:2996–3005, DOI: 10.1002/nop2.1011).
  29. Bernardi, L. A., Carnethon, M. R., de Chavez, P. J., Ikhena, D. E., Neff, L. M., Baird, D. D., & Marsh, E. E. "Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women". Obesity, 2017;25: 229–35. https://doi.org/10.1002/oby.21681.
  30. Hwang YI, Sung NY, Koo HS, Cha SH, Park CW, Kim JY, Yang KM, Song IO, Koong MK, Kang IS, et al. "Can high serum anti-Mullerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients? ". Clinical and Experimental Reproductive Medicine 2013;40:135–40. (https://doi. org/10.5653/cerm.2013.40.3.135).
  31. Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS & Ho HN. "The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome". Human Reproduction 2008;23:952–957. (https://doi. org/10.1093/humrep/den015).
  32. Xiying Zeng, Yinxiang Huang, Mulin Zhang, Yun Chen1, Jiawen Ye1, Yan Han, Danyan Ma, Xin Zheng, Xiaohong Yan and Changqin Liu. "Anti-Müllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS" Endocrine Connections, 2022; 11:e210243. (DOI: https://doi.org/10.1530/EC-21-0243).
  33. Lim SS, Norman RJ, Davies MJ & Moran LJ. "The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis". Obesity Reviews 2013;14:95–109. (https://doi.org/10.1111/j.1467- 789X.2012.01053.x).
  34. Lim SS, Davies MJ, Norman RJ & Moran LJ. "Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis". Human Reproduction Update 2012; 18: 618–37. (https://doi.org/10.1093/humupd/dms030).
  35. Feldman, Kathleen O'Neill, Samantha F. Butts, and Anuja Dokras "Anti Mullerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome, " Fertility and Sterility, " 2017; 107: 276–81.
  36. Eman H El-Adawy, Maha M Elshafei, Mohamed Sherif Abd Elgawad and Soma sheriff Abd EL Gawad,. "Relation of anthropometric measures and insulin resistance with Anti-Müllerian hormone in premenopausal women, " Journal of Metabolic Syndrome, " 2017;107:276–81.
  37. Xiying Zeng, Yinxiang Huang, Mulin Zhang, Yun Chen1, Jiawen Ye1, Yan Han, Danyan Ma, Xin Zheng, Xiaohong Yan and Changqin Liu. "Anti-Müllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS". Endocrine Connections, 2022; 11: e210243,. (DOI: https://doi.org/10.1530/EC-21-0243).
  38. Umit Gorkem, Ferit Kerim Kucukler, CihanTogrul, Şebnem Gulen, "Obesity Does not Compromise Ovarian Reserve Markers in Infertile Women, " Geburtsh Frauenheilk, " 2019;79: 79–85.
  39. Athanasia Piouka, Dimitrios Farmakiotis, Ilias Katsikis, Djuro Macut, Spiros Gerou, and Dimitrios Panidis. "Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels,"Am J Physiol Endocrinol Metab, " 2009;296: 238–43. doi:10.1152/ajpendo.90684.2008.
  40. Leana Alaa Abbas, Saad Merzah Hussein, Wathiq Essam Hameed. "Association between Anti Mullerian Hormone and Obesity," Indian Journal of Public Health Research and Development,201 ;10.
  41. So Ra Oh, Sun Yi Choe, Yeon Jean Cho. "Clinical application of serum anti-Müllerian hormone in women," Clinical and Experimental Reproductive 2019; 46:50-59.
Statistics
Article View: 298
PDF Download: 109


Journal Management System. Powered by iJournalPro.com